Evaluation of an immunochemotherapeutic protocol constituted of N-methyl meglumine antimoniate (Glucantime(®)) and the recombinant Leish-110f(®) + MPL-SE(®) vaccine to treat canine visceral leishmaniasis

The evaluation of the efficacy of an immunochemotherapy protocol to treat symptomatic dogs naturally infected with Leishmania chagasi was studied. This clinical trial had the purpose to test the combination of N-methyl meglumine antimoniate (Glucantime(®)) and the second generation recombinant vacci...

Descripción completa

Detalles Bibliográficos
Autores principales: Miret, Jorge, Nascimento, Evaldo, Sampaio, Weverton, França, João Carlos, Fujiwara, Ricardo Toshio, Vale, André, Dias, Edelberto Santos, Vieira, Edvá, Costa, Roberto Teodoro da, Mayrink, Wilson, Neto, Antonio Campos, Reed, Steven
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2008
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7127155/
https://www.ncbi.nlm.nih.gov/pubmed/18328956
http://dx.doi.org/10.1016/j.vaccine.2008.01.026

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7127155/
https://www.ncbi.nlm.nih.gov/pubmed/18328956
http://dx.doi.org/10.1016/j.vaccine.2008.01.026

Ejemplares similares